Literature DB >> 17218205

Cardiac resynchronization therapy and the emerging role of echocardiography (part 2): the comprehensive examination.

Deborah A Agler1, David B Adams, Alan D Waggoner.   

Abstract

Cardiac resynchronization therapy has been established as an adjunctive treatment for patients with severe left ventricular systolic dysfunction and medically refractory heart failure symptoms with a prolonged electrocardiographic QRS interval. Echocardiography has emerged as a useful method to evaluate patients who are considered for cardiac resynchronization therapy. This review outlines measurements of ventricular performance to be used in this patient population including echocardiographic optimization of cardiac resynchronization therapy device settings.

Entities:  

Mesh:

Year:  2007        PMID: 17218205     DOI: 10.1016/j.echo.2005.11.009

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  3 in total

1.  Measurement precision in the optimization of cardiac resynchronization therapy.

Authors:  Robert G Turcott; Ronald M Witteles; Paul J Wang; Randall H Vagelos; Michael B Fowler; Euan A Ashley
Journal:  Circ Heart Fail       Date:  2010-02-22       Impact factor: 8.790

2.  A general framework for dose optimization.

Authors:  Robert G Turcott; Hersh Sagreiya; Euan A Ashley; Russ B Altman; Amar K Das
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

Review 3.  Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologies.

Authors:  Maurizio Galderisi; Fabio Cattaneo; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2007-09-06       Impact factor: 2.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.